March 9, 2020 / 7:58 AM / in 22 days

BRIEF-Recordati Obtains FDA Approval For Isturisa In The US

March 9 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA:

* FOOD AND DRUG ADMINISTRATION (FDA) HAS APPROVED THE PLACING ON THE MARKET OF ISTURISA

* DRUG TO BE AVAILABLE ON THE US MARKET EITHER ON Q2 OR Q3 2020

* FDA DECISION ALSO CONFIRMS THE ORPHAN STATUS OF ISTURISA PROVIDI NG 7 YEARS OF MARKET EXCLUSIVITY

* ISTURISA IS A CORTISOL SYNTHESIS INHIBITOR FOR PATIENTS WITH CUSHING’S DISEASE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below